Phenylsulfonyl nitromethanes as aldose reductase inhibitors
申请人:Imperial Chemical Industries PLC
公开号:US05153227A1
公开(公告)日:1992-10-06
The invention concerns novel pharmaceutical compositions for use in the treatment of certain complications of diabetes and galactosemia and which contain a nitromethane derivative (or its non-toxic salt) as active ingredient. The nitromethane derivatives are inhibitors of the enzyme aldose reductase. Many of the inhibitors are novel and are provided, together with processes for their manufacture and use, as further features of the invention.